Drug
gadoquatrane
Marketed as AMBELVIST.
Generic name
gadoquatrane
Brand names
AMBELVIST
First FDA approval
2026-06-12
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA219627 | AMBELVIST | 2026-06-12 | BAYER HEALTHCARE |
Manufacturers
BAYER HEALTHCARE
Frequently asked questions
When was gadoquatrane FDA approved?
Earliest FDA approval on record: 2026-06-12.
What brand names are sold as gadoquatrane?
AMBELVIST.
Sources
Appeal a gadoquatrane denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com